Human Genome Epidemiology Literature Finder
|
Records 1 - 8 (of 8 Records) |
| Query Trace: Neoplasms and FEV[original query] |
|---|
| Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis. Chest 2003 May 123 (5): 1520-6. Morohashi Kazuaki, Takada Toshinori, Omori Kentaro, Suzuki Eiichi, Gejyo Fumita |
| The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema. American journal of respiratory and critical care medicine 2010 Mar 181 (5): 486-93. Lambrechts Diether, Buysschaert Ian, Zanen Pieter, Coolen Johan, Lays Natacha, Cuppens Harry, Groen Harry J M, Dewever Walter, van Klaveren Rob J, Verschakelen Johny, Wijmenga Cisca, Postma Dirkje S, Decramer Marc, Janssens W |
| MCP1 -2518 polymorphism and chronic obstructive pulmonary disease in Taiwanese men. Experimental lung research 2010 Jun 36 (5): 277-83. Liu Shih-Feng, Wang Chin-Chou, Fang Wen-Feng, Chen Yung-Che, Lin Meng-Ch |
| Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD. PloS one 2011 6 (2): e16476. Young Robert P, Hopkins Raewyn J, Whittington Chris F, Hay Bryan A, Epton Michael J, Gamble Gregory |
| Alpha-nicotinic acetylcholine receptor and tobacco smoke exposure: effects on bronchial hyperresponsiveness in children. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2012 Feb 23 (1): 40-9. Torjussen Tale M, Lødrup Carlsen Karin C, Munthe-Kaas Monica C, Mowinckel Petter, Carlsen Kai-Håkon, Helms Peter J, Gerritsen Jorrit, Whyte Moira K, Lenney Warren, Undlien Dag E, Shianna Kevin V, Zhu Guohua, Pillai Sreekumar |
| CHRNA3 genotype, nicotine dependence, lung function and disease in the general population. The European respiratory journal 2012 Dec 40 (6): 1538-44. Kaur-Knudsen Diljit, Nordestgaard Børge G, Bojesen Stig |
| Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility. Nature communications 2020 1 11 (1): 27. Kachuri Linda, Johansson Mattias, Rashkin Sara R, Graff Rebecca E, Bossé Yohan, Manem Venkata, Caporaso Neil E, Landi Maria Teresa, Christiani David C, Vineis Paolo, Liu Geoffrey, Scelo Ghislaine, Zaridze David, Shete Sanjay S, Albanes Demetrius, Aldrich Melinda C, Tardón Adonina, Rennert Gad, Chen Chu, Goodman Gary E, Doherty Jennifer A, Bickeböller Heike, Field John K, Davies Michael P, Dawn Teare M, Kiemeney Lambertus A, Bojesen Stig E, Haugen Aage, Zienolddiny Shanbeh, Lam Stephen, Le Marchand Loïc, Cheng Iona, Schabath Matthew B, Duell Eric J, Andrew Angeline S, Manjer Jonas, Lazarus Philip, Arnold Susanne, McKay James D, Emami Nima C, Warkentin Matthew T, Brhane Yonathan, Obeidat Ma'en, Martin Richard M, Relton Caroline, Davey Smith George, Haycock Philip C, Amos Christopher I, Brennan Paul, Witte John S, Hung Rayjean |
| Reduced FEV as Prognostic Factors in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors. Frontiers in medicine 2022 4 9 860733. Shen Yi-Luen, Shen Chia-I, Chiang Chi-Lu, Huang Hsu-Ching, Chou Kun-Ta, Chiu Chao-Hua, Chen Yuh-Min, Luo Yung-Hu |
- Page last reviewed:Feb 1, 2024
- Content source:

